These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37882870)

  • 1. A point-of-care urine test to predict adverse maternal and neonatal outcomes in Asian women with suspected preeclampsia.
    Wong NKL; Wah IYM; Wong STK; Nguyen-Hoang L; Lau CSL; Ip PNP; Leung HHY; Sahota DS; Poon LC
    Arch Gynecol Obstet; 2024 Aug; 310(2):981-990. PubMed ID: 37882870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point-of care urine test to predict preeclampsia development in Asian women with suspected preeclampsia.
    Wong STK; Sahota DS; Wong NKL; Wah IYM; Wang X; Lau SL; Chiu CPH; Ip PNP; Poon LC
    Pregnancy Hypertens; 2023 Jun; 32():28-34. PubMed ID: 37003112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
    Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
    Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
    Elia EG; Robb AO; Hemming K; Price MJ; Riley RD; French-Constant A; Denison FC; Kilby MD; Morris RK; Stock SJ
    Acta Obstet Gynecol Scand; 2017 May; 96(5):580-588. PubMed ID: 28247485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
    Reddy M; Fenn S; Rolnik DL; Mol BW; da Silva Costa F; Wallace EM; Palmer KR
    Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of maternal age on adverse pregnancy outcomes among primiparous women with singleton birth: a retrospective cohort study in urban areas of China.
    Li J; Yan J; Jiang W
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2250894. PubMed ID: 37635092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
    Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
    Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Urinary Misfolded Proteins for Imminent Prediction of Preeclampsia in Pregnant Women With Suspected Cases: Protocol for a Prospective Noninterventional Study.
    Tang H; Tian Y; Fang J; Yuan X; Yao M; Wang Y; Feng Y; Shu J; Ni Y; Yu Y; Wang Y; Liang P; Li X; Bai X
    JMIR Res Protoc; 2024 Apr; 13():e54026. PubMed ID: 38669061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
    Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S; Medley N; Williams MJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy, Delivery, and Neonatal Outcomes Associated With Maternal Obsessive-Compulsive Disorder: Two Cohort Studies in Sweden and British Columbia, Canada.
    Fernández de la Cruz L; Joseph KS; Wen Q; Stephansson O; Mataix-Cols D; Razaz N
    JAMA Netw Open; 2023 Jun; 6(6):e2318212. PubMed ID: 37314804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and neonatal outcomes of twin pregnancies complicated by gestational diabetes mellitus.
    Zhang Z; Mei L; Li L; Xiao J; Wu X; Yuan Y
    Endocrine; 2024 May; 84(2):388-398. PubMed ID: 37946069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of low-dose aspirin on adverse perinatal outcome: meta-analysis and meta-regression.
    Turner JM; Robertson NT; Hartel G; Kumar S
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):157-169. PubMed ID: 31479546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.